Related Experiment Video
Updated: Jun 1, 2026
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population
Paola Primatesta1, Estel Plana, Dietrich Rothenbacher
1Global Clinical Epidemiology, Novartis Pharma, Basel, Switzerland. paola.primatesta@novartis.com
Insights
Gout patients with comorbidities experience more flares, especially women. These conditions also influence gout treatment, with many patients not receiving adequate medication for acute attacks.
Area of Science:
- Rheumatology
- Epidemiology
- Pharmacology
Background:
- Gout is a common inflammatory arthritis with increasing prevalence.
- Comorbidities significantly impact gout severity and treatment strategies.
- Understanding patient characteristics and treatment patterns is crucial for managing gout.
Purpose of the Study:
- To characterize gout patients in a managed care population.
- To analyze gout treatment patterns and prevalent comorbidities.
- To investigate factors associated with gout flares.
Main Methods:
- Analysis of 177,637 gout patients (aged 20-89) from the US PharMetrics Patient-Centric Database (1996-2008).
- Inclusion criteria: at least 2 gout diagnosis claims and related prescriptions.
- Sex-specific Poisson regression models used to assess flare risk factors.
Main Results:
- Over half of patients had comorbidities, most commonly hypertension, dyslipidemia, and diabetes.
- Nonselective NSAIDs were most prescribed; 39% received no gout medication.
- Comorbidities were linked to increased anti-gout prescriptions and higher flare risk, particularly in women.
Conclusions:
- Comorbidities significantly alter gout treatment and acute attack frequency.
- Cardiometabolic conditions are associated with increased gout flare risk.
- Gout management requires addressing comorbidities for better outcomes.
Background:
Gout prevalence increased in recent years to become one of the most common causes of inflammatory arthritis in most industrialised countries. Comorbidities may affect the disease severity and treatment patterns. We describe the main characteristics of gout patients, gout-related treatment patterns and prevalent comorbidities in a managed care population.
Methods:
From the large US PharMetrics Patient-Centric Database, patients aged 20-89 with at least 2 claims for a diagnosis of gout (ICD9 274.xx) and related prescriptions between January 1, 1996 and December 31, 2008 were included. Gout flares were ascertained during follow-up. Sex-specific multivariable Poisson regression models were used to assess factors associated with number of flares.
Results:
177,637 gout patients were included (mean age 55.2 years; men 75.6%). Overall, more than half (58.1%) had any of the considered comorbidities; hypertension (36.1%), dyslipidemia (27.0%) and diabetes (15.1%) being the most common. Nonselective NSAIDs were the most commonly dispensed (in 38.7% of patients). Notably, 39% of patients did not receive any prescription medication for gout. Patients with comorbidities were significantly more likely to receive anti-gout prescriptions. During an acute episode the prescription of NSAIDs and colchicine increased; and 29.9% of patients received allopurinol. The risk of flares was associated with cardiometabolic comorbidities and older age in women (highest at age 60-69), while in men it decreased by age. Women with these conditions were 60% more likely to have flares (incidence rate ratio, IRR 1.60;1.48-1.74), while men were 10% (IRR 1.10; 1.06-1.13) more likely.
Conclusions:
Comorbidities affected gout treatment patterns and the occurrence and frequency of acute attacks. Cardiometabolic comorbidities, common in this patients' population, were associated with an increased risk of flares.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:21Rheumatic Heart Disease III: Medical Management
01:26Nephrotic Syndrome II : Assessment and Medical Management
01:30Urinary Tract Calculi III: Medical Management
01:28Chronic Kidney Disease III: Interprofessional Care
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...